IsisCB Explore

Article ID: CBB001320754

“Doriden von Ciba: Sleeping Pills, Pharmaceutical Marketing, and Thalidomide, 1955--1963 (2013)

History and Technology
Volume: 29, no. 2
Issue: 2
Pages: 153-168

Publication Date: 2013
Edition Details: Part of a special issue on the 20th century marketing and advertising of pharmaceuticals.
Language: English

Outside Links

WorldCat

Google Scholar

JSTOR

Academia.edu

Drug use Addictive behavior Pharmaceutical industry Sleep; rest Narcotics and drugs Marketing techniques 20th century, late Germany Switzerland

Although now forgotten, Swiss drug manufacturer CIBA's `Doriden' was well-known in the 1950s as one of the first barbiturate-free hypnotics. Its active principle was chemically related to the Thalidomide molecule, which proved to cause malformations in thousands of newborn children and to have neurotoxic effects in adults. Furthermore, Doriden was being sold in direct competition with Contergan (Thalidomide). This makes Doriden an interesting case study to gain new insight into drug marketing, as well as into risk perception and risk management before and during the Thalidomide disaster. In addition, it sheds light on the question of how `West Germany's worst drug disaster' was perceived by pharmaceutical companies other than Grünenthal, the German manufacturer of Contergan.

...More

Included in

Article Gaudillière, Jean-Paul; Thoms, Ulrike (2013) Pharmaceutical Firms and the Construction of Drug Markets: From Branding to Scientific Marketing. History and Technology (pp. 105-115). unapi

Citation URI

https://data.isiscb.org/isis/citation/CBB001320754/

Citations Indexes

Similar Citations

Article Thoms, Ulrike; (2013)
Standardizing Selling. Pharmaceutical Marketing, the Pharmaceutical Company and the Marketing Expert (1900--1980) (/isis/citation/CBB001320755/)

Book Norman Ohler; (2017)
Blitzed: Drugs in the Third Reich (/isis/citation/CBB528480075/)

Article Hüntelmann, Axel C.; (2013)
A Different Mode of Marketing? The Importance of Scientific Articles in the Marketing Process of Salvarsan (/isis/citation/CBB001320752/)

Book Nancy D. Campbell; (2020)
OD: Naloxone and the Politics of Overdose (/isis/citation/CBB601007525/)

Article Gaudillière, Jean-Paul; (2013)
From Propaganda to Scientific Marketing: Schering, Cortisone, and the Construction of Drug Markets (/isis/citation/CBB001320756/)

Book Sara E. Black; (2022)
Drugging France: Mind-Altering Medicine in the Long Nineteenth Century (/isis/citation/CBB100452937/)

Article Gaudillière, Jean-Paul; Thoms, Ulrike; (2013)
Pharmaceutical Firms and the Construction of Drug Markets: From Branding to Scientific Marketing (/isis/citation/CBB001320751/)

Book David Herzberg; (2020)
White Market Drugs: Big Pharma and the Hidden History of Addiction in America (/isis/citation/CBB940797249/)

Article Dehue, Trudy; (2004)
Historiography Taking Issue: Analyzing an Experiment with Heroin Abusers (/isis/citation/CBB000671310/)

Article Bonah, Christian; (2013)
“The Strophanthin Question”: Early Scientific Marketing of Cardiac Drugs in Two National Markets (France and Germany, 1900--1930). (/isis/citation/CBB001320753/)

Article Ulrich Koch; (2023)
“Heroin Mothers,” “Methadone Babies,” and the Medical Controversy over Methadone Maintenance in the Early 1970s (/isis/citation/CBB373395945/)

Book Bita Moghaddam; (2021)
Ketamine (/isis/citation/CBB929329054/)

Article Dehue, Trudy; (2002)
A Dutch Treat: Randomized Controlled Experimentation and the Case of Heroin Maintenance in the Netherlands (/isis/citation/CBB000400969/)

Thesis Glenn, Jason Edwin; (2005)
Medicalizing Addictions, Criminalizing Addicts: Race, Politics and Profit inNarratives of Addiction (/isis/citation/CBB001561587/)

Article Bennett, Cary; (2011)
Methadone Maintenance Treatment: Disciplining the “Addict” (/isis/citation/CBB001232068/)

Article Acker, Caroline Jean; (2010)
How Crack Found a Niche in the American Ghetto: The Historical Epidemiology of Drug-Related Harm (/isis/citation/CBB001036125/)

Article Mold, Alex; (2004)
The “British System” of Heroin Addiction Treatment and the Opening of Drug Dependence Units, 1965--1970 (/isis/citation/CBB000770532/)

Book Horace A. Bartilow; (2019)
Drug War Pathologies: Embedded Corporatism and U.S. Drug Enforcement in the Americas (/isis/citation/CBB525075418/)

Article Greene, Jeremy A.; (2013)
The Materiality of the Brand: Form, Function, and the Pharmaceutical Trademark (/isis/citation/CBB001320757/)

Article Quirke, Viviane; (2014)
Targeting the American Market for Medicines, ca. 1950s–1970s: ICI and Rhône-Poulenc Compared (/isis/citation/CBB001202354/)

Comments

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}